BenzodiazepinesAntipsychotic AgentsPirenzepineRisperidoneDibenzothiazepinesClozapineHaloperidolSchizophreniaPsychotic DisordersAntimanic AgentsPsychomotor AgitationSerotonin Uptake InhibitorsBipolar DisorderPharmacovigilancePromethazineEducation, Nursing, AssociateWeight GainAkathisia, Drug-InducedBasal Ganglia DiseasesDrug OverdosePsychiatric Status Rating ScalesCatalepsyDrug SubstitutionSchizophrenia, ParanoidNizatidineBiperidenPerphenazineFluoxetineSulpirideBrief Psychiatric Rating ScaleReceptors, Dopamine D2AstheniaEmergency Services, PsychiatricPiperazinesReceptor, Serotonin, 5-HT2ASchizophrenic PsychologyValproic AcidNeuroleptic Malignant SyndromeDouble-Blind MethodInjections, IntramuscularThiazolesTreatment OutcomeGalactorrheaDelayed-Action PreparationsRats, Sprague-DawleyForensic ToxicologyAffective Disorders, PsychoticQuinolonesDopamine AntagonistsAvoidance LearningDrug Therapy, CombinationPhencyclidineApomorphineLithium CompoundsSertralineDyskinesia, Drug-InducedObsessive BehaviorSerotonin AntagonistsDose-Response Relationship, DrugSchizophrenia, ChildhoodPrefrontal CortexDrug InteractionsNocturnal EnuresisTranquilizing AgentsPhenothiazinesLorazepamTherapeuticsChlorpromazineAnti-Anxiety AgentsLithium CarbonateReceptors, Dopamine D4PerazineDopamine AgonistsHeterocyclic Compounds with 4 or More RingsMolindoneAnorexia NervosaAntidepressive AgentsContraceptive AgentsTime FactorsCarbamazepineTriazinesAdrenergic AgentsReceptors, Dopamine D3Clinical Trials, Phase IV as TopicReceptors, DopamineStartle ReactionLithiumMuscle RigidityAnalysis of VarianceDrug Administration ScheduleReceptors, SerotoninTicsReceptors, Serotonin, 5-HT2AggressionTabletsMotor ActivityPharmacoepidemiologySingle-Blind MethodMicrodialysisAdministration, Oral